1.
Min Liu, Jonathan G. Faris, Amanda R. Panfil, Cody J. Warren. How new approach methods are reshaping virology research. Journal of Virology. 2026;100(4):e0132625. doi:10.1128/jvi.01326-25
United States
1.
Tyna Dao, Nakissa Sadrieh. A CDER perspective: Landscape of New Approach Methodologies (NAMs) submitted in drug development programs. Regulatory toxicology and pharmacology: RTP. 2026;165:106007. doi:10.1016/j.yrtph.2025.106007
1.
Patricia L. Bishop, Vicki L. Dellarco, Douglas C. Wolf. Is the 90-day dog study necessary for pesticide toxicity testing? Critical Reviews in Toxicology. 2023;53(4):207-228. doi:10.1080/10408444.2023.2221987
1.
Yuling Han, Xiaohua Duan, Liuliu Yang, et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2021;589(7841):270-275. doi:10.1038/s41586-020-2901-9
1.
Hongbing Wang, Paul C. Brown, Edwin C. Y. Chow, et al. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration. Clinical and Translational Science. 2021;14(5):1659-1680. doi:10.1111/cts.13066
1.
Michael S. Lauer, Jamie Doyle, Joy Wang, Deepshikha Roychowdhury. Associations of topic-specific peer review outcomes and institute and center award rates with funding disparities at the National Institutes of Health. eLife. 2021;10:e67173. doi:10.7554/eLife.67173
1.
Marissa M. Shams-White, Rolando Barajas, Roxanne E. Jensen, et al. Systems epidemiology and cancer: A review of the National Institutes of Health extramural grant portfolio 2013-2018. PloS One. 2021;16(4):e0250061. doi:10.1371/journal.pone.0250061
1.
S. Vincent Rajkumar. The high cost of prescription drugs: causes and solutions. Blood Cancer Journal. 2020;10(6):71. doi:10.1038/s41408-020-0338-x
1.
Talia H. Swartz, Ann-Gel S. Palermo, Sandra K. Masur, Judith A. Aberg. The Science and Value of Diversity: Closing the Gaps in Our Understanding of Inclusion and Diversity. The Journal of Infectious Diseases. 2019;220(S2):S33-S41. doi:10.1093/infdis/jiz174
1.
Kathy Archibald, Katya Tsaioun, J. Gerry Kenna, Pandora Pound. Better science for safer medicines: the human imperative. Journal of the Royal Society of Medicine. 2018;111(12):433-438. doi:10.1177/0141076818812783